Group One Trading
CRDF icon

Group One Trading’s Cardiff Oncology CRDF Stock Holding History

Group One Trading’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260 Hold
200
– – ﹤0.01% 7361
2026
Q1 		$324 Sell
200
-9,500
-98% -$19.5K ﹤0.01% 7363
2025
Q4 		$27.3K Sell
9,700
-4,900
-34% -$11.4K ﹤0.01% 6107
2025
Q3 		$30.1K Sell
14,600
-2,100
-13% -$5.8K ﹤0.01% 6367
2025
Q2 		$52.6K Sell
16,700
-18,800
-53% -$57.3K ﹤0.01% 5536
2025
Q1 		$111K Sell
35,500
-24,300
-41% -$96.1K ﹤0.01% 4507
2024
Q4 		$260K Buy
59,800
+30,300
+103% +$94.7K ﹤0.01% 3733
2024
Q3 		$78.8K Buy
29,500
+17,100
+138% +$40.4K ﹤0.01% 4357
2024
Q2 		$27.5K Buy
12,400
+1,700
+16% +$6.41K ﹤0.01% 4984
2024
Q1 		$57.1K Buy
10,700
+7,400
+224% +$19.7K ﹤0.01% 4605
2023
Q4 		$4.88K Sell
3,300
-200
-6% -$242 ﹤0.01% 6515
2023
Q3 		$4.87K Sell
3,500
-84,400
-96% -$142K ﹤0.01% 6714
2023
Q2 		$129K Buy
87,900
+7,400
+9% +$11.9K ﹤0.01% 4365
2023
Q1 		$133K Buy
+80,500
New +$138K ﹤0.01% 4038
2022
Q4 		– Sell
-7,200
Closed -$11K – 7345
2022
Q3 		$11K Sell
7,200
-10,800
-60% -$26K ﹤0.01% 6419
2022
Q2 		$40K Buy
18,000
+2,600
+17% +$4.35K ﹤0.01% 5744
2022
Q1 		$38K Buy
15,400
+7,200
+88% +$25.5K ﹤0.01% 6310
2021
Q4 		$49K Sell
8,200
-46,700
-85% -$278K ﹤0.01% 6352
2021
Q3 		$366K Buy
54,900
+1,500
+3% +$9.42K ﹤0.01% 4535
2021
Q2 		$355K Buy
53,400
+39,800
+293% +$338K ﹤0.01% 4592
2021
Q1 		$126K Buy
13,600
+9,800
+258% +$119K ﹤0.01% 5440
2020
Q4 		$68K Sell
3,800
-7,100
-65% -$125K ﹤0.01% 4809
2020
Q3 		$155K Buy
+10,900
New +$72K ﹤0.01% 3852

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Group One Trading's CRDF Position: Q2 2026 in Review

Group One Trading sold out of Cardiff Oncology (CRDF) in Q2 2026, closing a stake of 25,175 shares — an estimated $40K sold.

Group One Trading first reported a position in CRDF in Q2 2021 and held it in 18 quarters. The position peaked at $482K in Q3 2021. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Group One Trading reported no remaining Cardiff Oncology position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 25,175 Cardiff Oncology shares in Q2 2026, an estimated $40K.
  • Group One Trading first reported a position in Cardiff Oncology in Q2 2021 and held it in 18 quarters.
  • Group One Trading's Cardiff Oncology position peaked at $482K in Q3 2021.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.